•  Summary 
  •  
  •  Actions 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 

A05574 Summary:

BILL NOA05574E
 
SAME ASSAME AS S00696-E
 
SPONSORGrannis (MS)
 
COSPNSRGottfried, Cohen A, Eddington, Espaillat, Fields, Jacobs, Peoples, Burling, Englebright, Hevesi, Schroeder
 
MLTSPNSRAubertine, Boyland, Brennan, Cahill, Christensen, Colton, Cook, Cymbrowitz, Dinowitz, Galef, Glick, Gordon, Greene, Gunther, Heastie, Hooper, John, Koon, Lafayette, Latimer, Lavelle, Lavine, Lifton, Lopez, Lupardo, Magee, McDonough, McEneny, Meng, Millman, Nolan, O'Donnell, Ortiz, Paulin, Pheffer, Rivera J, Rivera N, Robinson, Rosenthal, Tonko, Weinstein, Weisenberg, Zebrowski
 
Add Art 2 Title VI SS265 - 265-e, Pub Health L
 
Requires the commissioner to conduct a cost/benefit analysis of pharmaceutical advertising and promotional activities associated with the provision of prescription drugs to citizens in this state.
Go to top